Future research should focus on integrating genetic, epigenetic, and environmental data to create comprehensive models of cancer susceptibility. Advances in omics technologies and bioinformatics can facilitate the discovery of novel biomarkers and pathways involved in cancer risk. Additionally, personalized medicine approaches that tailor prevention and treatment strategies based on individual susceptibility profiles hold great promise for reducing the burden of cancer.
